comparemela.com

Page 5 - Biopharmaceuticals Ltd News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Union minister Jitendra Singh launches Omicron-specific vaccine for Covid | Latest News India

A few days ago, this vaccine got the nod from the office of the Drug Control General of India (DCGI) for Emergency Use Authorization (EUA). | Latest News India

India s first mRNA-based Omicron-specific booster vaccine from Pune-based Gennova gets DCGI approval

Gennova Biopharmaceuticals mRNA Covid-19 booster vaccine, Gemcovac Om , has received emergency use authorisation from the office of the Drugs Controller General of India for the Omicron variant. The vaccine is the first booster Covid-19 vaccine developed in India against the highly transmissible Omicron variant and has demonstrated robust immune responses in phase 3 clinical trials. It is stable at two to eight degrees Centigrade and has been developed using Gennova s indigenous platform technology, supported under Mission Covid Suraksha .

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.